Stockscreener 앱 받기
26.98
1.70%
0.45
시간 외 거래:
26.94
-0.04
-0.15%
전일 마감가:
$26.53
열려 있는:
$26.48
하루 거래량:
5.23M
Relative Volume:
0.93
시가총액:
$3.03B
수익:
-
순이익/손실:
$-99.15M
주가수익비율:
-29.01
EPS:
-0.93
순현금흐름:
$-74.25M
1주 성능:
-0.26%
1개월 성능:
-20.72%
6개월 성능:
-3.44%
1년 성능:
-51.29%
1일 변동 폭
$25.77
$27.29
1주일 범위
$25.77
$28.26
52주 변동 폭
$18.92
$81.73
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
VKTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
26.98 | 2.98B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Goldman | Neutral |
| 2025-02-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-07 | 개시 | Citigroup | Neutral |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-11-22 | 개시 | B. Riley Securities | Buy |
| 2024-11-04 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-11 | 개시 | JP Morgan | Overweight |
| 2024-06-27 | 개시 | Morgan Stanley | Overweight |
| 2024-05-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 재확인 | Oppenheimer | Outperform |
| 2024-03-07 | 개시 | Jefferies | Buy |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2023-05-31 | 재개 | ROTH MKM | Buy |
| 2023-03-28 | 재확인 | Maxim Group | Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 개시 | BMO Capital Markets | Outperform |
| 2020-05-05 | 개시 | Chardan Capital Markets | Buy |
| 2020-05-01 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | Oppenheimer | Outperform |
| 2019-06-25 | 개시 | Stifel | Buy |
| 2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 재확인 | Maxim Group | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-18 | 재확인 | Maxim Group | Buy |
| 2018-09-18 | 재확인 | Raymond James | Outperform |
| 2018-07-20 | 개시 | SunTrust | Buy |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-01 | 재확인 | Laidlaw | Buy |
| 2018-05-31 | 재확인 | Maxim Group | Buy |
| 2018-03-26 | 재개 | H.C. Wainwright | Buy |
| 2017-11-28 | 재확인 | Maxim Group | Buy |
| 2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Can swing trading help recover from Viking Therapeutics Inc. lossesM&A Rumor & Daily Stock Trend Reports - Newser
Can Viking Therapeutics Inc. withstand a market correctionQuarterly Earnings Summary & Weekly Hot Stock Watchlists - خودرو بانک
Is Viking Therapeutics Inc. stock heavily shortedEarnings Beat & Daily Price Action Insights - خودرو بانک
Can Viking Therapeutics Inc. outperform in the next rallyQuarterly Investment Review & AI Based Buy and Sell Signals - خودرو بانک
Why Viking Therapeutics Inc. is moving today2025 Market Outlook & High Conviction Buy Zone Alerts - Newser
Will Viking Therapeutics Inc. benefit from macro trends2025 Risk Factors & Expert Approved Trade Ideas - Newser
Market reaction to Viking Therapeutics Inc.’s recent newsMarket Volume Report & Detailed Earnings Play Strategies - Newser
Is Viking Therapeutics Inc. exposed to political riskLayoff News & Fast Exit and Entry Trade Guides - خودرو بانک
Institutional scanner results for Viking Therapeutics Inc.Market Risk Report & Reliable Trade Execution Plans - Newser
Jim Cramer Expects Palantir To Reach New All-Time High - Benzinga
Forecasting Viking Therapeutics Inc. price range with options dataJuly 2025 Opening Moves & Technical Pattern Alert System - Newser
Exit strategy if you’re trapped in Viking Therapeutics Inc.Swing Trade & Community Trade Idea Sharing - Newser
Is Viking Therapeutics Inc. stock entering bullish territory2025 Valuation Update & AI Powered Market Trend Analysis - Newser
Down 34%, Should You Buy the Dip on Viking Therapeutics? - AOL.com
Published on: 2025-09-05 06:53:36 - Newser
Quantitative breakdown of Viking Therapeutics Inc. recent moveJuly 2025 Selloffs & Smart Investment Allocation Insights - Newser
Why Viking Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 PostEarnings & Real-Time Volume Trigger Notifications - Newser
Cramer's Market Picks: Palantir to $200, Viking Therapeutics a No-Go - AInvest
Viking Therapeutics Rises as Phase 3 Trials and Oral Formulation Progress Accelerate - MSN
What is Viking Therapeutics Inc. s P E ratio telling usShort Setup & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years - AOL.com
When is the best time to exit Viking Therapeutics Inc.July 2025 Trends & Growth Oriented Trade Recommendations - Newser
Using data filters to optimize entry into Viking Therapeutics Inc.July 2025 Decliners & Fast Gaining Stock Strategy Reports - Newser
Portfolio Update: Does Viking Therapeutics Inc. stock reflect fundamentals2025 Earnings Surprises & Safe Swing Trade Setups - khodrobank.com
What MACD signals say about Viking Therapeutics Inc.July 2025 Technicals & Verified Momentum Stock Watchlist - Newser
Price momentum metrics for Viking Therapeutics Inc. explained2025 Big Picture & Entry and Exit Point Strategies - Newser
Visual analytics tools that track Viking Therapeutics Inc. performance2025 Buyback Activity & Free Long-Term Investment Growth Plans - Newser
How to monitor Viking Therapeutics Inc. with trend dashboardsEntry Point & Fast Moving Market Watchlists - Newser
Published on: 2025-09-03 00:51:15 - Newser
Analyzing drawdowns of Viking Therapeutics Inc. with statistical toolsSell Signal & Reliable Price Action Trade Plans - Newser
What’s the recovery path for long term holders of Viking Therapeutics Inc.M&A Rumor & Community Trade Idea Sharing Platform - Newser
Does Viking Therapeutics Inc. stock reflect fundamentalsJuly 2025 Short Interest & Low Drawdown Trading Techniques - خودرو بانک
How to interpret RSI for Viking Therapeutics Inc. stockQuarterly Earnings Report & Long-Term Capital Growth Strategies - Newser
Can a trend reversal in Viking Therapeutics Inc. lead to recoveryWeekly Trade Summary & Detailed Earnings Play Strategies - Newser
Is Viking Therapeutics Inc. Forming a Bottom Pattern getLinesFromResByArray error: size == 0 - thegnnews.com
Applying big data sentiment scoring on Viking Therapeutics Inc.2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - Newser
How to use Fibonacci retracement on Viking Therapeutics Inc.Day Trade & Free Community Consensus Stock Picks - Newser
Viking Therapeutics Loses 20% in a Month: How to Play the Stock - sharewise.com
Real time social sentiment graph for Viking Therapeutics Inc.2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Is Viking Therapeutics Inc. stock ready for a breakoutJuly 2025 WrapUp & Fast Gain Swing Alerts - Newser
Using AI based signals to follow Viking Therapeutics Inc.2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Can Viking Therapeutics Inc. ride the EV waveJuly 2025 Final Week & Consistent Profit Trade Alerts - خودرو بانک
What MACD and RSI say about Viking Therapeutics Inc.July 2025 Opening Moves & AI Based Buy/Sell Signal Reports - Newser
What recovery options are there for Viking Therapeutics Inc.2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
Viking Therapeutics Inc (VKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Viking Therapeutics Inc 주식 (VKTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ZANTE GREG | Chief Financial Officer |
Jul 03 '25 |
Sale |
27.76 |
4,266 |
118,428 |
168,660 |
| Mancini Marianna | Chief Operating Officer |
Jul 03 '25 |
Sale |
27.77 |
4,266 |
118,473 |
377,535 |
1.40%
자본화:
|
볼륨(24시간):